Mao, L., Chen, Y., Chen, J., Lin, J., Ye, T., Zhang, F., Zhang, L., Sun, P., Li, H., Mo, Y., Si, L. (2025). A phase 1b study investigating the safety, tolerability and preliminary efficacy of HX009 in post-immune checkpoint inhibitor (CPI) therapy advanced melanoma patients.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e14502